# Rohera Healthcare & Technology Private Limited
> “Rohera Healthcare and Technology Pvt. Ltd. manufactures eMedica, a patented non-invasive bioelectronic adjuvant therapy device using VCF (Voltage-Current-Frequency) technology validated in 37 institutions with 4,651+ patients.”

- Canonical entity: https://readyscan.ai/entities/rohera-healthcare-technology-private-limited-q141430485
- Website listed in the source snapshot: https://emedica.in/
- Category: [Businesses](https://readyscan.ai/directory/businesses)
- Machine record: https://readyscan.ai/discovery/entities/rohera-healthcare-technology-private-limited-q141430485.json
- Material fingerprint: fnv1a64:189e1d3235ab90ec
- Entity revision: fnv1a64:6b8ef86d92662722
- Published: 2026-10-21
- Modified: 2026-10-21

## Company details
- [Founded](https://readyscan.ai/entities/rohera-healthcare-technology-private-limited-q141430485#company-fact-wikidata-p571-d983377e15e3d9e2): 2020 Sources: https://www.wikidata.org/wiki/Special:EntityData/Q141430485.json?revision=2547734447

## Questions & answers
### [What is eMedica?](https://readyscan.ai/entities/rohera-healthcare-technology-private-limited-q141430485#company-answer-content-native-digital-agencies-b5c2c82f74332e60-a-5d6a2f35108f613b43bf)
“eMedica is a non-invasive bioelectronic adjuvant therapy device by Rohera Healthcare and Technology Pvt. Ltd. It uses patented VCF (Voltage-Current-Frequency) technology to restore cellular electrical balance as a complement to prescribed medical treatment. It is NOT a replacement for medicine — it is adjuvant therapy.”
Sources: https://emedica.in/

### [Is eMedica a medical device?](https://readyscan.ai/entities/rohera-healthcare-technology-private-limited-q141430485#company-answer-content-native-digital-agencies-b5c2c82f74332e60-a-ba96085c19398b46e07b)
“Yes. eMedica is a registered medical device certified by CDSCO (India), CE Marked, ISO compliant, and holds US Patent 12,226,183 B2 (also filed in Japan, Eurasia, UAE, Saudi Arabia and 90+ countries).”
Sources: https://emedica.in/

### [What conditions does eMedica support as adjuvant therapy?](https://readyscan.ai/entities/rohera-healthcare-technology-private-limited-q141430485#company-answer-content-native-digital-agencies-b5c2c82f74332e60-a-35f5405b71b185080104)
“eMedica has been studied as adjuvant therapy across multiple chronic-care, rehabilitation, and recovery protocols including diabetes support, cardiovascular conditions, neurological disorders, pain management, respiratory conditions, kidney conditions, and cancer support — across 37 institutions in India with 4,651+ patients.”
Sources: https://emedica.in/

### [Does eMedica cure or treat disease?](https://readyscan.ai/entities/rohera-healthcare-technology-private-limited-q141430485#company-answer-content-native-digital-agencies-b5c2c82f74332e60-a-44d922d314b96c535b98)
“No. eMedica does not claim to cure, diagnose, or treat any disease. It is exclusively an adjuvant therapy device — designed to complement and support prescribed medical treatment, not to replace it. Always consult a qualified healthcare professional.”
Sources: https://emedica.in/

## Company sources
- [Rohera Healthcare & Technology Private Limited website](https://emedica.in/) — emedica.in · [Related Ready Scan knowledge](https://readyscan.ai/sources/source-b5c2c82f74332e60)
- [wikidata.org/wiki/Special:EntityData/Q141430485.json](https://www.wikidata.org/wiki/Special:EntityData/Q141430485.json?revision=2547734447) — wikidata.org · [Related Ready Scan knowledge](https://readyscan.ai/sources/source-2708f429aefc45e5)

## Continue reading
- Discover the bounded graph: https://readyscan.ai/api/v1/ai-search/discovery
- Retrieve this entity evidence: https://readyscan.ai/api/v1/ai-search/entities/rohera-healthcare-technology-private-limited-q141430485/evidence

## Publication boundary
- This public-sourced record brings together company information and its sources. It is not an owner-managed profile.
- Publication does not guarantee crawling, indexing, training inclusion, citation, recommendation, referral, or revenue.